About this Research Topic
Obstructive sleep apnea (OSA) is a common disorder in the general population around the globe. Treatment strategies and management decision priorities may considerably vary depending on the specialist first consulting the patient.
OSA poses quite often a multidisciplinary challenge with a clinically relevant interplay between respiratory, neurologic, cognitive and behavioural disorders in the same patient. Therefore, co-operation among specialists of quite different disciplines is often imperative to ensure comprehensive care of such complex patients.
More specifically, associated disorders, such as insomnia, mild cognitive impairment, specific cognitive decline in the attention domain, associated cerebral white matter changes, Alzheimer's disease, Huntington's disease or other dementias, Parkinson's disease, restless legs syndrome and cerebrovascular involvement including stroke may pose specific challenges to the management of these patients with a combined disorder.
The aim of this Research Topic is to provide a current state of the knowledge and practise on diagnosing and treating patients with these combined disorders from a clinical point of view. Emphasis will be put on high-degree evidence involving therapeutic strategies as well as recognition of potential areas of future clinical research aimed at optimizing management of such patients.
Review articles, original papers or case reports will highlight therapeutic priorities including positive airway therapy, pharmacotherapy, cognitive behavioural therapy, physical therapy or surgery for management of OSA and the aforementioned associated conditions.
OSA poses quite often a multidisciplinary challenge with a clinically relevant interplay between respiratory, neurologic, cognitive and behavioural disorders in the same patient. Therefore, co-operation among specialists of quite different disciplines is often imperative to ensure comprehensive care of such complex patients.
More specifically, associated disorders, such as insomnia, mild cognitive impairment, specific cognitive decline in the attention domain, associated cerebral white matter changes, Alzheimer's disease, Huntington's disease or other dementias, Parkinson's disease, restless legs syndrome and cerebrovascular involvement including stroke may pose specific challenges to the management of these patients with a combined disorder.
The aim of this Research Topic is to provide a current state of the knowledge and practise on diagnosing and treating patients with these combined disorders from a clinical point of view. Emphasis will be put on high-degree evidence involving therapeutic strategies as well as recognition of potential areas of future clinical research aimed at optimizing management of such patients.
Review articles, original papers or case reports will highlight therapeutic priorities including positive airway therapy, pharmacotherapy, cognitive behavioural therapy, physical therapy or surgery for management of OSA and the aforementioned associated conditions.
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
